AU Patent

AU2017269335B2 — EGFR inhibitor compounds

Assigned to Recurium IP Holdings LLC · Expires 2021-07-01 · 5y expired

What this patent protects

Disclosed herein are nitrogen-containing bicyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.

USPTO Abstract

Disclosed herein are nitrogen-containing bicyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.

Drugs covered by this patent

Patent Metadata

Patent number
AU2017269335B2
Jurisdiction
AU
Classification
—
Expires
2021-07-01
Drug substance claim
No
Drug product claim
No
Assignee
Recurium IP Holdings LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.